Share Pin 0 Shares

Video: CNBC discusses the news that Amgen is working on a drug to lower the risk of a heart attack. The process involves a specific gene that some people carry that makes you less likely to have a heart attack compared to people that don’t carry that specific gene.

Amgen (AMGN) is down 2.70% YTD. Amgen holds a 4.37% holding weighting in the SPDR Healthcare ETF (XLV) and a 8.11% holding weighting in the Nasdaq Biotech ETF (IBB).

http://video.cnbc.com/gallery/?video=3000519115